t:slim X2 insulin pump with Interoperable Technology, Control-IQ+ technology, REF: 1014070, 1014071, 1014072, 1014073, and User Guide when using Dexcom G7 sensor; Tandem Mobi insulin pump with Interoperable Technology, Control-IQ+ technology, REF: 1014801, 1014811, 1014813, and User Guide when using Dexcom G7 sensor
Published October 29, 2025 · Recall initiated: August 5, 2025
Summary
FDA records medical device Class II recall Z-0232-2026, published October 29, 2025 and initiated August 5, 2025. Recalling firm: Tandem Diabetes Care, Inc.; Status: Ongoing; Reported quantity: 122,958; Lot: t:slim X2, UDI-DI: 00389152407012, 00389152407111, 00389152407210, 00389152407319 with software versions 7.9.0.1 and 7.10.1, User Guide versions not including and prior to: AW-1014562 Revision D; Tandem Mobi, UDI-DI: 00389152480114, 00389152481111, 00389152481319 with software version 7.9.0.1, User Guide versions not including and prior to: AW-1014938 Revision C. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
A software defect in versions 7.9.0.1 and 7.10.1 of the pump software for Tandem t:slim X2 and version 7.9.0.1 of the Tandem Mobi pump with Control-IQ+ technology that are paired with a G7 sensor may result in an unexpected automatic insulin correction bolus (autobolus ) which could result in hypoglycemia.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Tandem Diabetes Care, Inc.
- Distributor
- US nationwide distribution including Puerto Rico.
- Lot
- t:slim X2, UDI-DI: 00389152407012, 00389152407111, 00389152407210, 00389152407319 with software versions 7.9.0.1 and 7.10.1, User Guide versions not including and prior to: AW-1014562 Revision D; Tandem Mobi, UDI-DI: 00389152480114, 00389152481111, 00389152481319 with software version 7.9.0.1, User Guide versions not including and prior to: AW-1014938 Revision C
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDATandem Mobi Insulin Pump, Models: 1004004, 1010750, 1012676, 1012719, 1013655, 1013656, 1013501, 1013700,November 11, 2026
- FDABrand Name: Tandem t:slim mobile application Product Name: t:slim Mobile Application, iOS Model/CatalogOctober 7, 2026
- FDAFuse ULTRA Foot Plating System Instructions for Use. Models: OS200400, OS200401, OS328017, OS200020L,October 29, 2025
- FDAOral Probe (Product code 02893-000), accessory used with Welch Allyn SureTemp Plus 690 (Product codesOctober 29, 2025
- FDAShanghai United Imaging Healthcare Co., Ltd. Positron Emission Tomography and Computed Tomography SystemOctober 29, 2025
- FDAt:connect mobile app used in conjunction with t:slim X2 insulin pump with Control-IQ technologyMay 15, 2024
Questions about this recall
Was t:slim X2 insulin pump with Interoperable Technology, Control-IQ+ technology, REF: 1014070, 1014071, 1014072, 1014073, and User Guide when using Dexcom G7 sensor; Tandem Mobi insulin pump with Interoperable Technology, Control-IQ+ technology, REF: 1014801, 1014811, 1014813, and User Guide when using Dexcom G7 sensor recalled?
Yes. FDA published recall Z-0232-2026 on October 29, 2025. Reported hazard: A software defect in versions 7.9.0.1 and 7.10.1 of the pump software for Tandem t:slim X2 and version 7.9.0.1 of the Tandem Mobi pump with Control-IQ+ technology that are paired with a G7 sensor may result in an unexpected automatic insulin correction bolus (autobolus ) which could result in hypoglycemia.
What should I do if I have this product?
Voluntary: Firm initiated · Letter